The current price of KALV is $27.00 — it has remained unchanged since the previous close. Data as of Jun 10, 2026.
KALV is flat over the past week, flat over the past month and up 74.08% over the past year. The price is above its 200-day moving average of $17.09.
Analysts' average 12-month price target for KALV is $28.50, which implies 5.56% upside from the current price. Individual estimates range from $27.00 to $32.00.
Of the 7 analysts covering KalVista Pharmaceuticals, Inc., 1 rates it a buy and 6 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
KalVista Pharmaceuticals, Inc. has a market capitalization of $1.44B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
KalVista Pharmaceuticals, Inc. has not paid any dividends over the past year.
In the latest trading session KALV moved between $26.98 and $27.00, a range of 0.07% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of KalVista Pharmaceuticals, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for KalVista Pharmaceuticals, Inc. is strong buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks KALV has traded between $10.41 and $27.00. The current price is at its 52-week high.
Figures as of Jun 10, 2026. This information is provided for general purposes only and is not investment advice.